Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma

Journal of Gastroenterology and Hepatology (Australia)

Volumn 27, Issue 1, 2012, Pages 173-180

  Zhan, Da Qian ^a   Wei, Shuang ^a   Liu, Cong ^a   Liang, Bin Yong ^a   Ji, Gui Bao ^a   Chen, Xiao Ping ^a   Xiong, Min ^a   Huang, Zhi Yong ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Expression; Hepatocellular carcinoma; Knockdown; Metastasis; N cadherin

Indexed keywords

NERVE CELL ADHESION MOLECULE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SURVIVAL; CELL AGGREGATION; CELL MIGRATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; METASTASIS POTENTIAL; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; TUMOR DIFFERENTIATION; WESTERN BLOTTING;

EID: 84155192621     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2011.06847.x     Document Type: Article

References (34)

1. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 1907-17.
2. Chen XP, Huang ZY. Surgical treatment of hepatocellular carcinoma in China: surgical techniques, indications, and outcomes. Langenbecks Arch. Surg. 2005; 390: 259-65.
3. Fidler IJ. The pathogenesis of cancer metastasis: the "seed and soil" hypothesis revisited. Nat. Rev. Cancer 2003; 3: 453-8.
4. Pantel K, Brakenhoff RH. Dissecting the metastatic cascade. Nat. Rev. Cancer 2004; 4: 448-56.
5. Conacci-Sorrell M, Zhurinsky J, Ben-Ze'ev A. The cadherin-catenin adhesion system in signaling and cancer. J. Clin. Invest 2002; 109: 987-91.
6. Christofori G, Semb H. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem. Sci. 1999; 24: 73-6.
7. Matsumura T, Makino R, Mitamura K. Frequent down-regulation of E-cadherin by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomas. Clin. Cancer Res. 2001; 7: 594-9.
8. Wei Y, Van Nhieu JT, Prigent S, Srivatanakul P, Tiollais P, Buendia MA. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features. Hepatology 2002; 36: 692-701.
9. Adachi Y, Takeuchi T, Sonobe H, Ohtsuki Y. An adiponectin receptor, T-cadherin, was selectively expressed in intratumoral capillary endothelial cells in hepatocellular carcinoma: possible cross talk between T-cadherin and FGF-2 pathways. Virchows Arch. 2006; 448: 311-8.
10. Riou P, Saffroy R, Chenailler C etal. Expression of T-cadherin in tumor cells influences invasive potential of human hepatocellular carcinoma. FASEB J. 2006; 20: 2291-301.
11. Yan Q, Zhang ZF, Chen XP etal. Reduced T-cadherin expression and promoter methylation are associated with the development and progression of hepatocellular carcinoma. Int. J. Oncol. 2008; 32: 1057-63.
12. Derycke LD, Bracke ME. N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signalling. Int. J. Dev. Biol. 2004; 48: 463-76.
13. Rosivatz E, Becker I, Bamba M etal. Neoexpression of N-cadherin in E-cadherin positive colon cancers. Int. J. Cancer 2004; 111: 711-9.
14. Lascombe I, Clairotte A, Fauconnet S etal. N-cadherin as a novel prognostic marker of progression in superficial urothelial tumors. Clin. Cancer Res. 2006; 12: 2780-7.
15. Tomita K, van Bokhoven A, van Leenders GJ etal. Cadherin switching in human prostate cancer progression. Cancer Res. 2000; 60: 3650-4.
16. Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J. Cell Biol. 2000; 148: 779-90.
17. Li G, Satyamoorthy K, Herlyn M. N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. Cancer Res. 2001; 61: 3819-25.
18. Rieger-Christ KM, Lee P, Zagha R etal. Novel expression of N-cadherin elicits in vitro bladder cell invasion via the Akt signaling pathway. Oncogene 2004; 23: 4745-53.
19. Darai E, Scoazec JY, Walker-Combrouze F etal. Expression of cadherins in benign, borderline, and malignant ovarian epithelial tumors: a clinicopathologic study of 60 cases. Hum. Pathol. 1997; 28: 922-8.
20. Kashima T, Kawaguchi J, Takeshita S etal. Anomalous cadherin expression in osteosarcoma. Possible relationships to metastasis and morphogenesis. Am. J. Pathol. 1999; 155: 1549-55.
21. Cho SB, Lee KH, Lee JH etal. Expression of E- and N-cadherin and clinicopathology in hepatocellular carcinoma. Pathol. Int. 2008; 58: 635-42.
22. Seo DD, Lee HC, Kim HJ etal. Neural cadherin overexpression is a predictive marker for early postoperative recurrence in hepatocellular carcinoma patients. J. Gastroenterol. Hepatol. 2008; 23: 1112-8.
23. Li Y, Tang Y, Ye L etal. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray. J. Cancer Res. Clin. Oncol. 2003; 129: 43-51.
24. Maeda M, Johnson KR, Wheelock MJ. Cadherin switching: essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition. J. Cell Sci. 2005; 118: 873-87.
25. Shimazui T, Kojima T, Onozawa M, Suzuki M, Asano T, Akaza H. Expression profile of N-cadherin differs from other classical cadherins as a prognostic marker in renal cell carcinoma. Oncol. Rep. 2006; 15: 1181-4.
26. Huang ZY, Wu Y, Hedrick N, Gutmann DH. T-cadherin-mediated cell growth regulation involves G2 phase arrest and requires p21(CIP1/WAF1) expression. Mol. Cell. Biol. 2003; 23: 566-78.
27. Tran NL, Adams DG, Vaillancourt RR, Heimark RL. Signal transduction from N-cadherin increases Bcl-2. Regulation of the phosphatidylinositol 3-kinase/Akt pathway by homophilic adhesion and actin cytoskeletal organization. J. Biol. Chem. 2002; 277: 32905-14.
28. Qi J, Chen N, Wang J, Siu CH. Transendothelial migration of melanoma cells involves N-cadherin-mediated adhesion and activation of the beta-catenin signaling pathway. Mol. Biol. Cell. 2005; 16: 4386-97.
29. Kashima T, Nakamura K, Kawaguchi J etal. Overexpression of cadherins suppresses pulmonary metastasis of osteosarcoma in vivo. Int. J. Cancer 2003; 104: 147-54.
30. Asano K, Kubo O, Tajika Y, Takakura K, Suzuki S. Expression of cadherin and CSF dissemination in malignant astrocytic tumors. Neurosurg. Rev. 2000; 23: 39-44.
31. Asano K, Duntsch CD, Zhou Q etal. Correlation of N-cadherin expression in high grade gliomas with tissue invasion. J. Neurooncol. 2004; 70: 3-15.
32. Agathanggelou A, Bieche I, Ahmed-Choudhury J etal. Identification of novel gene expression targets for the Ras association domain family 1 (RASSF1A) tumor suppressor gene in non-small cell lung cancer and neuroblastoma. Cancer Res. 2003; 63: 5344-51.
33. Hagihara A, Miyamoto K, Furuta J etal. Identification of 27 5′ CpG islands aberrantly methylated and 13 genes silenced in human pancreatic cancers. Oncogene 2004; 23: 8705-10.
34. Liu WB, Cui ZH, Ao L etal. Aberrant methylation accounts for cell adhesion-related gene silencing during 3-methylcholanthrene and diethylnitrosamine induced multistep rat lung carcinogenesis associated with overexpression of DNA methyltransferases 1 and 3a. Toxicol. Appl. Pharmacol. 2011; 251: 70-8.